Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

XENE

Xenon Pharmaceuticals (XENE)

Xenon Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:XENE
DatumZeitQuelleÜberschriftSymbolFirma
13/11/202422h01GlobeNewswire Inc.Xenon to Present at Upcoming Investor ConferencesNASDAQ:XENEXenon Pharmaceuticals Inc
12/11/202422h36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XENEXenon Pharmaceuticals Inc
12/11/202422h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
12/11/202422h01GlobeNewswire Inc.Xenon Reports Q3 2024 Financial Results and Business UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
05/11/202422h01GlobeNewswire Inc.Xenon to Report Q3 2024 Financial Results on November 12, 2024NASDAQ:XENEXenon Pharmaceuticals Inc
02/10/202422h28GlobeNewswire Inc.Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
09/09/202414h30GlobeNewswire Inc.Xenon Showcases Azetukalner Data at 15th European Epilepsy CongressNASDAQ:XENEXenon Pharmaceuticals Inc
12/08/202414h30GlobeNewswire Inc.Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating OfficerNASDAQ:XENEXenon Pharmaceuticals Inc
09/08/202422h57Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:XENEXenon Pharmaceuticals Inc
08/08/202422h36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XENEXenon Pharmaceuticals Inc
08/08/202422h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
08/08/202422h01GlobeNewswire Inc.Xenon Reports Q2 2024 Financial Results and Business UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
01/08/202422h01GlobeNewswire Inc.Xenon to Report Q2 2024 Financial Results on August 8, 2024NASDAQ:XENEXenon Pharmaceuticals Inc
13/07/202403h44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
13/07/202403h44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
12/06/202423h32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202423h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202423h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202423h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202423h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202423h30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202422h22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202422h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202422h01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
28/05/202414h30GlobeNewswire Inc.Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual MeetingNASDAQ:XENEXenon Pharmaceuticals Inc
09/05/202422h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XENEXenon Pharmaceuticals Inc
09/05/202422h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
09/05/202422h01GlobeNewswire Inc.Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
08/05/202422h01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024NASDAQ:XENEXenon Pharmaceuticals Inc
07/05/202422h01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:XENE

Kürzlich von Ihnen besucht

Delayed Upgrade Clock